This resolution condemns the Food and Drug Administration's decision in January 2023 to remove in-person dispensing requirements for mifepristone.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line